GlassScriptPhysician profile
Shivan Satheesh Shetty
NPI 1508446196
$1,625.47
in general payments reported to CMS, 2019-2025
17 companies · $1,327 in 2025
The $1,327 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $298 · 2025: $1,327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,625.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $306.09 | 2024-2025 | Mounjaro, Zepbound, Kisunla |
| Pfizer INC. | $304.73 | 2024-2025 | |
| Abbvie INC. | $286.26 | 2024-2025 | |
| Novo Nordisk INC | $118.22 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.61 | 2024-2025 | Xifaxan |
| Exact Sciences Corporation | $108.97 | 2024-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $90.90 | 2024-2025 | |
| Glaxosmithkline, LLC. | $64.19 | 2025 | Shingrix, Arexvy, Bexsero |
| Xeris Pharmaceuticals, INC. | $41.45 | 2025 | Gvoke Hypopen |
| Boston Scientific Corporation | $34.26 | 2025 | Intracept |
| Phathom Pharmaceuticals, INC. | $28.04 | 2025 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $28.04 | 2025 | Airsupra |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.82 | 2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $21.38 | 2025 | Rexulti |
| Hologic Sales and Service, LLC | $19.86 | 2025 | Thinprep 2000 Processor, Aptima, Third Wave |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18.21 | 2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $15.44 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shivan Shetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.